CEBIS Team
Meet the CEBIS team working across clinical research, project management, quality assurance, clinical supply and technology.
Meet the CEBIS Team
Alina Iordache, RN, MS
Alina Iordache, in her capacity as the Lead Project Manager Europe, assumes the responsibility of strategically developing and providing medical oversight for the clinical trials conducted by our organization. Additionally, she supervises the clinical and medical affairs, pharmacovigilance, strategic regulatory, and data management and medical writing teams.
Alina possesses a wealth of industry experience spanning 15 years in the fields of medical, safety, quality assurance, regulatory affairs, and training, which she brings to bear in her current position. Additionally, she possesses a total of twelve years of extensive clinical research experience, during which she served as an international project manager for more than 200 clinical studies.
Alina has provided support to various therapeutic domains through her work, and she now maintains an active registered nurse license. Since 2020, she has held the designation of a QPPV given by European Medicine Agency (EMA).
Alina successfully obtained her MSc in Psychology from Pitesti University in Romania, followed by a Registered Nurse Degree from “FEG” College of Pitesti, also in Romania.
Dr Sontoshi Patro
Dr. Sontoshi Patro is a seasoned clinical research and life sciences executive with more than 20 years of experience across medicine, clinical research, drug and cell therapy development, and program management. As Vice President, North America, and Global Lead for assigned projects, she provides strategic and commercial leadership for CEBIS USA, driving growth, cultivating client partnerships, and expanding the organization’s presence across the global clinical research landscape.
Dr. Sontoshi brings extensive experience leading clinical and operational initiatives across academia and industry, including end-to-end global clinical trial execution and support for IND, NDA, and BLA submissions. Her expertise spans traditional therapeutics, stem cell research, RNA therapeutics, cell therapy, and immunotherapy, enabling her to translate complex scientific challenges into evidence-driven strategies, optimized clinical trial designs, and operational excellence. She has also served as a primary scientific reviewer for the boards of Baylor College of Medicine, Texas Children’s Hospital, and MD Anderson Cancer Center, with a particular focus on oncology.
Combining medical, scientific, operational, and business expertise, Dr. Sontoshi bridges strategy and execution to deliver meaningful value for clients throughout the clinical development lifecycle. She earned her medical degree from Berhampur University, completed Translational Research Education through the NIH, received genetics training through Harvard’s Office of External Education, and holds an MBA from Texas Woman’s University. Her leadership and client-focused approach are instrumental in advancing CEBIS USA’s growth and delivering innovative, high-quality solutions for increasingly complex development programs.
Teresa Diaz
Professional in Clinical Operations and Project Management with over 25 years of experience in Drug Development and Clinical Research.
Her experience is related to lead complex programs and studies at global level, i.e AbbVie and Merck , combined with years working in clinical operations and Project management in the pharma, CROs and Biotech industry as, GSK, Novartis, IQVIA etc,
Teresa is making an effort to expand our operations into the business zones of Israel, South America and Japan because these zones are beneficial to our company.
Teresa’s professional network includes people in the pharmaceutical industry in both the American continent , Europe and Intercontinental regions . for our successful expansion it is critical her expertise working for biotech businesses and that she is actively involved in South American affairs.
Peter Kaiser, PhD
Dr. Peter Kaiser is tasked with formulating the overarching vision and executing the corresponding strategy for the clinical Quality Assurance department. The scope of this responsibility encompasses the formulation, implementation, and sustenance of audit strategies that are rooted in risk assessment. These strategies are specifically designed to scrutinize both internal and external audits pertaining to Good Clinical Practice (GCP).
The primary objective of these audits is to ascertain that clinical trials are conducted in strict adherence to relevant regulations, guidelines outlined by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), established procedures by CEBIS, and clinical trial protocols.
Peter is tasked with the deployment of comprehensive GCP inspection readiness plans. This responsibility entails the overall administration of a sizable cross-functional team consisting of colleagues from the CEBIS organization. Additionally, Peter has responsibility for the establishment, upkeep, and ongoing enhancement of departmental protocols and practices. They also provide assistance in implementing and continuously improving GCP systems. This role facilitates and encourages the establishment of a GCP (Good Clinical Practice) compliant setting with both internal and external stakeholders, while simultaneously assuring the utilization of the established Quality Systems of CEBIS. Peter holds the responsibility of overseeing and managing a team of direct reports, which may include contracted Consultants. This individual is required to demonstrate exceptional organizational skills and exemplify strong leadership qualities. This job serves as the internal subject matter expert within the Quality Assurance department of GCP.
Inder Bhayana
Inder oversees the complete spectrum of clinical supply chain management, encompassing tasks such as sourcing comparators, manufacturing IMP/placebo, handling imports, managing storage, and overseeing global distribution.
Over the years, he has cultivated valuable collaborations with suppliers and affiliated entities. With a professional background that spans various global locations and includes prominent organizations like Bayer, Mylan Pharmaceuticals, and Shoppers Drug Mart, Inder brings his wealth of experience to the forefront in supporting CEBIS and its partners in their clinical trials, ensuring the smooth operation of supply chain management.
Dr. Sherifuddin Sheriff
Dr. Sheriff is a dynamic leader in clinical research having more than 23 years of experience in the field, and he was formally trained as a physician and has undertaken a variety of entrepreneurial ventures as well.
He has spent over 25 years in the medical field working in hospitals, clinical research organizations, and assisting pharmaceutical companies worldwide in their drug development process.
In addition to his expertise in clinical research, he has conducted research on global health issues that benefited society.
He has participated in research projects in India, the US, Canada, Japan, Europe, Middle East, Asia, and Africa, and has served as a consultant on clinical research for several US and European pharmaceutical companies. Additionally, he has advised sponsors on regulatory compliance requirements and interacted with regulatory authorities during regulatory audits.
In India, Southeast Asia, and the Middle East, Dr Sheriff advises on building relationships and provides local insight into the pharmaceutical and drug device industries. Furthermore, he works with operations in building client-focused teams.
Kashif Haq PhD
Dr. Kashif Haq is a seasoned professional with over two decades’ experience in drug development and clinical research. With an impressive track record working within the Pharmaceutical Industry, Kashif brings a wealth of knowledge and expertise to the field.
Dr. Haq’s experience spans across various domains, including CRO operations, system development, CRO setup, quality management, life science training, business development (clinical research and formulations), project management, and global supply chain management.
Throughout his distinguished career, Dr. Haq has demonstrated exceptional leadership qualities. He has consistently and effectively led cross-functional teams, successfully navigating complex challenges both in India and during international assignments.
Dr. Haq’s unique perspective and proficiency in the aforementioned areas make him a valuable asset to any organization.
Rahul Jayarama R
A highly experienced software developer and project manager, he has 11+ years of experience in full-stack development of enterprise-level Cloud applications and has spent 8+ years in areas of Project Management and End-User Support. With sound knowledge of Data Management Practices, Designing, Business Process, and Process Validations in Clinical Research domain.